Premium
C‐reactive protein can be used to predict the therapeutic effects of nivolumab in patients with metastatic renal cell carcinoma
Author(s) -
Teishima Jun,
Murata Daiki,
Hasegawa Yasuhisa,
Moriyama Hiroyuki,
Mita Koji,
Matsubara Akio
Publication year - 2019
Publication title -
international journal of urology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.172
H-Index - 67
eISSN - 1442-2042
pISSN - 0919-8172
DOI - 10.1111/iju.14084
Subject(s) - medicine , nivolumab , renal cell carcinoma , metastatic melanoma , oncology , cancer research , intensive care medicine , melanoma , cancer , immunotherapy
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom